Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at Aeon Biopharma Inc fell by 33.83m. Cash Flow from Financing totalled 14.00m or -- of revenues. In addition the company used 47.83m for operations while cash from investing was breakeven.
Cash flow per share | -9.18 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -0.8106 |
---|---|
Tangible book value per share | -0.8106 |
More ▼
Balance sheet in USDView more
Current ratio | 0.221 |
---|---|
Quick ratio | -- |
Total debt/total equity | -- |
---|---|
Total debt/total capital | -- |
More ▼